| Total (n = 378) | HIV – (n = 193) | HIV + (n = 185) | p value * |
---|---|---|---|---|
Menopausal stage, n (%) | Â | Â | Â | Â |
 Pre-menopause | 173(45.8) | 94(48.7) | 79(42.7) | 0.278 |
 Peri-menopause | 51(13.5) | 28(14.5) | 23(12.4) |  |
 Post menopause | 154(40.7) | 71(36.8) | 83(44.9) |  |
Total MRS symptoms, n (%) | Â | Â | Â | Â |
 No, little (≤ 4) | 177(46.8) | 101(52.3) | 76(41.1) | 0.005 |
 Mild (5–8) | 97(25.7) | 52(26.9) | 45(24.3) |  |
 Moderate (9–16) | 81(21.4) | 35(18.1) | 46(24.9) |  |
 Severe (≥ 17) | 23(6.1) | 5(2.6) | 18(9.7) |  |
Somatic symptomsub-domain, n (%) | Â | Â | Â | Â |
 No, little (0–2) | 190(50.3) | 102(52.9) | 88(47.6) | 0.250 |
 Mild (3–4) | 91(24.1) | 50(25.9) | 41(22.2) |  |
 Moderate (5–8) | 82(21.7) | 35(18.1) | 47(25.4) |  |
 Severe (≥ 9) | 15(4.0) | 6(3.1) | 9(4.9) |  |
Psychological symptomsub-domain, n (%) | Â | Â | Â | Â |
 No, little (0–1) | 228(60.3) | 135(70.0) | 93(50.3) | < 0.001 |
 Mild (2–3) | 75(19.8) | 30(15.5) | 45(24.3) |  |
 Moderate (4–6) | 53(14.0) | 26(13.5) | 27(14.6) |  |
 Severe (≥ 7) | 22(5.8) | 2(1.0) | 20(10.8) |  |
Urogenital symptomsub-domain, n (%) | Â | Â | Â | Â |
 No, little (0) | 172(45.5) | 100(51.8) | 72(38.9) | 0.009 |
 Mild (1) | 63(16.7) | 36(18.7) | 27(14.6) |  |
 Moderate (2–3) | 88(23.3) | 35(18.1) | 53(28.7) |  |
 Severe (≥ 4) | 55(14.5) | 22(11.4) | 33(17.8) |  |
HRQoL, mean (SD) | 26.4(3.5) | 26.5(3.3) | 26.3(3.7) | 0.642 |